Kanagawa, Japan

Koji Watanabe

USPTO Granted Patents = 93 

 

 

Average Co-Inventor Count = 2.7

ph-index = 16

Forward Citations = 747(Granted Patents)

Forward Citations (Not Self Cited) = 733(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Otsu, JA (1976 - 1977)
  • Niiza, JP (1980)
  • Ohtsu, JP (1982)
  • Otsu, JP (1987 - 1988)
  • Kawasaki, JP (1995 - 2000)
  • Kamakura, JP (2000)
  • Mie, JP (2003)
  • Shiga, JP (1992 - 2004)
  • Aichi, JP (1991 - 2011)
  • Hiratsuka, JP (1997 - 2011)
  • Kusatsu, JP (1988 - 2015)
  • Asaka, JP (2015)
  • Fujisawa, JP (1981 - 2017)
  • Resnsselaer, NY (US) (2018)
  • Ibaraki, JP (2020)
  • Kanagawa, JP (1994 - 2021)
  • Rensselaer, NY (US) (2017 - 2021)
  • Kitaibaraki, JP (2014 - 2022)
  • Fukushima, JP (2023)
  • Tochigi, JP (2023)
  • Yokohama, JP (1989 - 2024)

Company Filing History:


Years Active: 1976-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Calcium-Sensing Receptor
Nanosheet Transistor Devices
Complementary Metal-Oxide-Semiconductor
Resin Molding
Sealing Devices
Silicon-Germanium Fin Structure
MOSFET Structures
Automobile Tires
Image Forming Apparatus
Aromatic Compounds
Hybrid Gate Stack Integration
93 patents (USPTO):Explore Patents

Title: **Koji Watanabe: Innovator in Patents and Research**

Introduction

Koji Watanabe, located in Kanagawa, Japan, is a renowned inventor with an impressive portfolio of 80 patents. His work primarily focuses on groundbreaking innovations in the fields of pharmaceuticals and semiconductor technology, showcasing his diverse expertise and contribution to science.

Latest Patents

Among Watanabe's latest patents is a significant advancement in the form of heterocyclic compounds that possess calcium-sensing receptor antagonistic activity. This invention provides a potential therapeutic agent for preventing or treating heart failure, pulmonary hypertension, and other related conditions. The compounds, represented by a specific formula, are pivotal in medical innovation, promising to enhance treatment strategies in cardiovascular health.

Another notable patent is for a gate oxide structure used in nanosheet transistor devices. This innovation involves a distinct method of forming a semiconductor structure, comprising first and second nanosheet stacks on a substrate. The intricacies of forming alternating sacrificial layers define a new approach that could enhance the performance of semiconductor devices by optimizing their structural integrity.

Career Highlights

Watanabe has made significant contributions during his tenure at various companies. He has worked with Nok Corporation, where his research focused on advancing technology for consumer electronics. Additionally, his role at Nifco Inc. further solidified his reputation as a leading innovator in the industry, allowing him to extend his expertise into practical applications of his patents.

Collaborations

Throughout his career, Koji Watanabe has collaborated with notable coworkers such as Yusuke Yoshida and Ruqiang Bao. These partnerships have led to the exchange of innovative ideas and advancements in technology, enriching the development of the patents he holds.

Conclusion

Koji Watanabe exemplifies the spirit of innovation, with a rich history of patents that encompass both health care and semiconductor technology. His continued work and collaboration with others in the field illustrate the importance of teamwork in fostering creativity and achieving significant milestones in technological advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…